# Effect of, OAT3, on the Renal Secretion of Cefotaxime

> **NCT00187655** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 24 (actual)

## Conditions studied

- Focus Groups

## Interventions

- **DRUG:** Cefotaxime

## Key facts

- **NCT ID:** NCT00187655
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2011-12
- **Final completion:** 2013-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187655, "Effect of, OAT3, on the Renal Secretion of Cefotaxime". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00187655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*